MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As reported in Tech Journal South ... Tengion, a company that creates working organs using a patient’s own cells, plans to raise $40 million in an initial public offering of stock. Tengion has a research laboratory and pilot facility in Winston Salem, NC, where co-scientific founder Dr. Anthony Atala heads the Wake Forest Institute for Regenerative Medicine...

See clip from MedTech-IQ Videolibrary on Dr Atala: Regenerative Medicine: Dr Anthony Atala, MD, Wake Forest describes ... ...

...The company’s patented integrated technology platform  was developed over the past two decades by scientists at Children’s Hospital Boston (a teaching affiliate of Harvard Medical School), MIT, and the Wake Forest Institute for Regenerative Medicine ...

...Founded in 2003, the company has no revenue ... But, the company owns or licenses over 30 US patents and patent applications and over 100 international patents and filings related to its platform and nine product candidates...

... Dr. Atala and his lab have created working human bladders on cell scaffolds, a unique sort of construction work. Part of his research is funded by the U.S. Armed Forces Institute of Regenerative Medicine (AFIRM) ...

...Tengion’s corporate headquarters and commercial manufacturing facility are in East Norriton, Pennsylvania. The company has research offices, a development laboratory and a pilot manufacturing facility in Winston Salem, North Carolina.

Read on at: http://www.techjournalsouth.com/2010/03/regenerative-tissue-firm-te...

ENJOY!

CC

Views: 50

© 2017   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service